Insider / Skyward Specialty Insurance Group, Inc.
Duffy Sean W
EVP & CHIEF CLAIMS OFFICER at Skyward Specialty Insurance Group, Inc.
Duffy Sean W, EVP & CHIEF CLAIMS OFFICER at Skyward Specialty Insurance Group, Inc., has disclosed 18 transactions in SKWD since January 5, 2026: 0 purchases (0 open-market buys) and 5 sales, worth about $403K at the reported prices. The latest was filed May 8, 2026, 2 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Duffy Sean W made no purchases and 5 sales worth $403K, plus 13 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Duffy Sean W has traded 1 stock on record; the largest by dollars is SKWD.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 10 | 38,567 | — |
| F | Shares withheld for tax | 5 | 8,700 | $403K |
| A | Grant or award | 3 | 7,210 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 18 | 0 | 5 · $403K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| SKWD | Option / conversion M | May 6, 2026 | May 8, 2026 | 2d | 2,861 | — | — | derivative | Form 4 ↗ | |
| SKWD | Sell F | May 6, 2026 | May 8, 2026 | 2d | 1,671 | $44 | $73K | Form 4 ↗ | ||
| SKWD | Option / conversion M | May 6, 2026 | May 8, 2026 | 2d | 3,805 | — | — | Form 4 ↗ | ||
| SKWD | Other A | February 25, 2026 | February 27, 2026 | 2d | 4,326 | — | — | derivative | Form 4 ↗ | |
| SKWD | Other A | February 25, 2026 | February 27, 2026 | 2d | 1,442 | — | — | derivative | Form 4 ↗ | |
| SKWD | Other A | February 25, 2026 | February 27, 2026 | 2d | 1,442 | — | — | derivative | Form 4 ↗ | |
| SKWD | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 2,861 | — | — | derivative | Form 4 ↗ | |
| SKWD | Sell F | February 26, 2026 | February 27, 2026 | 1d | 1,391 | $46 | $64K | Form 4 ↗ | ||
| SKWD | Option / conversion M | February 25, 2026 | February 27, 2026 | 2d | 3,318 | — | — | Form 4 ↗ | ||
| SKWD | Option / conversion M | January 12, 2026 | January 14, 2026 | 2d | 5,000 | — | — | derivative | Form 4 ↗ | |
| SKWD | Option / conversion M | January 12, 2026 | January 14, 2026 | 2d | 5,000 | — | — | derivative | Form 4 ↗ | |
| SKWD | Sell F | January 12, 2026 | January 14, 2026 | 2d | 2,095 | $46 | $97K | Form 4 ↗ | ||
| SKWD | Option / conversion M | January 12, 2026 | January 14, 2026 | 2d | 5,000 | — | — | Form 4 ↗ | ||
| SKWD | Sell F | January 12, 2026 | January 14, 2026 | 2d | 2,276 | $46 | $105K | Form 4 ↗ | ||
| SKWD | Option / conversion M | January 12, 2026 | January 14, 2026 | 2d | 5,000 | — | — | Form 4 ↗ | ||
| SKWD | Option / conversion M | January 1, 2026 | January 5, 2026 | 4d | 2,861 | — | — | derivative | Form 4 ↗ | |
| SKWD | Sell F | January 1, 2026 | January 5, 2026 | 4d | 1,267 | $51 | $65K | Form 4 ↗ | ||
| SKWD | Option / conversion M | January 1, 2026 | January 5, 2026 | 4d | 2,861 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 8, 2026 | Form 4 | 0001936008-26-000008 | 3 | published | EDGAR ↗ |
| February 27, 2026 | Form 4 | 0001936008-26-000006 | 6 | published | EDGAR ↗ |
| January 14, 2026 | Form 4 | 0001936008-26-000004 | 6 | published | EDGAR ↗ |
| January 5, 2026 | Form 4 | 0001936008-26-000002 | 3 | published | EDGAR ↗ |
Other insiders at Skyward Specialty Insurance Group, Inc.
- Kapadia Sandip A Head of Actuarial 21 rows
- Schmitt Thomas N CHIEF PEOPLE & ADMIN.OFFICER 21 rows
- Robinson Andrew S Chairman & CEO, Skyward Group 20 rows
- Bodnar Dan PK CHIEF INFORMATION OFFICER 18 rows
- Burkhart John A III President, US P&C, Skyward Grp 18 rows
- HAUSHILL MARK W EVP & CFO, Skyward Group 18 rows
- Kuczinski Anthony J Director 13 rows
- Ashe Gena L Director 6 rows
- Khan Shakoor Corp. Dev. Officer 4 rows
- McHarg Taryn Leonie CFO - Apollo 4 rows
Everyone on file, with contracts and lobbying under the company's name: Skyward Specialty Insurance Group, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 18 | January 5, 2026 | May 8, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.